Jubilant Pharmova Limited — Important, 02-08-2025: General Updates

Jubilant Pharmova's subsidiary completed a USFDA pre-approval inspection at its Roorkee solid dosage facility, resulting in 4 observations. The company will submit an action plan to address these. Importantly, this site's US market revenue accounts for less than one percent of Jubilant Pharmova's total revenues, suggesting a minimal financial impact from these observations on the overall business.